Literature DB >> 18167135

Recombinant human TSH associated with radioiodine does not have further effects on thyroid volume and function after 2 years.

G J Paz-Filho, C O Mesa, G A Carvalho, C A Goedert, H Graf.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 18167135     DOI： 10.1111/j.1365-2265.2007.03165.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN： 0300-0664            Impact factor:   3.478


× No keyword cloud information.
  2 in total

1.  Long-term outcome after radioiodine therapy with adjuvant rhTSH treatment: comparison between patients with non-toxic and pre-toxic large multinodular goitre.

Authors:  M Giusti; V Caorsi; L Mortara; M Caputo; E Monti; M Schiavo; M C Bagnara; F Minuto; M Bagnasco
Journal:  Endocrine       Date:  2013-04-26       Impact factor: 3.633

2.  Long-term outcome of low-activity radioiodine administration preceded by adjuvant recombinant human TSH pretreatment in elderly subjects with multinodular goiter.

Authors:  Massimo Giusti; Mauro Caputo; Iolanda Calamia; Mariaclaudia Bagnara; Enrica Ceresola; Mara Schiavo; Michele Mussap; Diego Ferone; Francesco Minuto; Marcello Bagnasco
Journal:  Thyroid Res       Date:  2009-06-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.